Kweli Thompson
CIK: 0002137804
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MDT
Medtronic plc
Officer
Discretionary Trading P&L
Holdings
About Thompson Kweli
Thompson Kweli (SEC CIK 0002137804) files insider reports with the SEC as EVP & President, Neuroscience of Medtronic plc (MDT).
Signal8 holds 2 ownership filings by Thompson Kweli (1 Form 3, 1 Form 4), filed between Jun 26, 2026 and Aug 4, 2026. Those filings report 2 transactions, from Jul 31, 2026 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Thompson Kweli's filings is in MINNEAPOLIS, MN.
Recent filings by Thompson Kweli
Other insiders filing for Medtronic plc (MDT)
- Lofton Kevin E, Director
- Marinaro Michael, EVP, Pres MedSurg and Americas
- Martha Geoffrey, Chairman and CEO
- KIIL HARRY SKIP, EVP & President Cardiovascular
- Blomquist Denise L., Chief Accounting Officer
- Walter Matthew R., SVP, Chief HR Officer